Search research articles
Contact Us
Filters
Showing results (91-100 of 112) with videos related to
Page
of 12
Sort By:
European Urology
|
October 13, 2020
The Clinicopathologic and Molecular Landscape of Clear Cell Papillary Renal Cell Carcinoma: Implications in Diagnosis and Management
Stanley Weng, Renzo G DiNatale, Andrew Silagy, et al.
World Journal of Urology
|
March 29, 2021
A qualitative framework of non-selection factors for cytoreductive nephrectomy
Andrew W Silagy, Kyrollis Attalla, Renzo G Dinatale, et al.
British Journal of Anaesthesia
|
July 25, 2020
Impact of intraoperative opioid and adjunct analgesic use on renal cell carcinoma recurrence: role for onco-anaesthesia
Andrew W Silagy, Margaret L Hannum, Roy Mano, et al.
Cancer Medicine
|
August 16, 2014
The impact of genetic heterogeneity on biomarker development in kidney cancer assessed by multiregional sampling
Alexander Sankin, Abraham A Hakimi, Nina Mikkilineni, et al.
Cancer
|
July 21, 2021
Evolving biological associations of upfront cytoreductive nephrectomy in metastatic renal cell carcinoma
Andrew W Silagy, Ritesh R Kotecha, Stanley Weng, et al.
The Lancet. Oncology
|
December 25, 2019
Transcriptomic signatures related to the obesity paradox in patients with clear cell renal cell carcinoma: a cohort study
Alejandro Sanchez, Helena Furberg, Fengshen Kuo, et al.
Kidney Cancer Journal : Official Journal of the Kidney Cancer Association
|
July 28, 2021
Resource-efficient pooled sequencing expands translational impact in solid tumors
Renzo G DiNatale, Roy Mano, Vladimir Makarov, et al.
JCO Precision Oncology
|
February 17, 2022
Persistent Severe Hyperlactatemia and Metabolic Derangement in Lethal <i>SDHB</i>-Mutated Metastatic Kidney Cancer: Clinical Challenges and Examples of Extreme Warburg Effect
Chung-Han Lee, Gunes Gundem, William Lee, et al.
BJU International
|
August 17, 2023
Localised non-metastatic sarcomatoid renal cell carcinoma: a 31-year externally verified study
Kyle A Blum, Andrew W Silagy, Andrea Knezevic, et al.
Cancer
|
October 28, 2015
Validation and genomic interrogation of the MET variant rs11762213 as a predictor of adverse outcomes in clear cell renal cell carcinoma
A Ari Hakimi, Irina Ostrovnaya, Anders Jacobsen, et al.
Page
of 12
Search research articles
Search
Showing results (91-100 of 112) with videos related to
Sort By:
Page
of 12
European Urology
|
October 13, 2020
The Clinicopathologic and Molecular Landscape of Clear Cell Papillary Renal Cell Carcinoma: Implications in Diagnosis and Management
Stanley Weng, Renzo G DiNatale, Andrew Silagy, et al.
World Journal of Urology
|
March 29, 2021
A qualitative framework of non-selection factors for cytoreductive nephrectomy
Andrew W Silagy, Kyrollis Attalla, Renzo G Dinatale, et al.
British Journal of Anaesthesia
|
July 25, 2020
Impact of intraoperative opioid and adjunct analgesic use on renal cell carcinoma recurrence: role for onco-anaesthesia
Andrew W Silagy, Margaret L Hannum, Roy Mano, et al.
Cancer Medicine
|
August 16, 2014
The impact of genetic heterogeneity on biomarker development in kidney cancer assessed by multiregional sampling
Alexander Sankin, Abraham A Hakimi, Nina Mikkilineni, et al.
Cancer
|
July 21, 2021
Evolving biological associations of upfront cytoreductive nephrectomy in metastatic renal cell carcinoma
Andrew W Silagy, Ritesh R Kotecha, Stanley Weng, et al.
The Lancet. Oncology
|
December 25, 2019
Transcriptomic signatures related to the obesity paradox in patients with clear cell renal cell carcinoma: a cohort study
Alejandro Sanchez, Helena Furberg, Fengshen Kuo, et al.
Kidney Cancer Journal : Official Journal of the Kidney Cancer Association
|
July 28, 2021
Resource-efficient pooled sequencing expands translational impact in solid tumors
Renzo G DiNatale, Roy Mano, Vladimir Makarov, et al.
JCO Precision Oncology
|
February 17, 2022
Persistent Severe Hyperlactatemia and Metabolic Derangement in Lethal <i>SDHB</i>-Mutated Metastatic Kidney Cancer: Clinical Challenges and Examples of Extreme Warburg Effect
Chung-Han Lee, Gunes Gundem, William Lee, et al.
BJU International
|
August 17, 2023
Localised non-metastatic sarcomatoid renal cell carcinoma: a 31-year externally verified study
Kyle A Blum, Andrew W Silagy, Andrea Knezevic, et al.
Cancer
|
October 28, 2015
Validation and genomic interrogation of the MET variant rs11762213 as a predictor of adverse outcomes in clear cell renal cell carcinoma
A Ari Hakimi, Irina Ostrovnaya, Anders Jacobsen, et al.
Page
of 12